AMARIN CORP PLC\UK Increase (Decrease) in Inventories
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Inventories of -$31.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-29
- AMARIN CORP PLC\UK increase (decrease) in inventories for the quarter ending 2026-06-30 was -$19.51M.
- AMARIN CORP PLC\UK increase (decrease) in inventories for the quarter ending 2026-03-31 was -$12.32M.
- AMARIN CORP PLC\UK increase (decrease) in inventories for the quarter ending 2025-12-31 was $2.10M.
- AMARIN CORP PLC\UK increase (decrease) in inventories for the quarter ending 2025-09-30 was -$17.02M.
- AMARIN CORP PLC\UK increase (decrease) in inventories for fiscal 2025 was -$34.88M.
- AMARIN CORP PLC\UK increase (decrease) in inventories for fiscal 2024 was -$105.44M.
- AMARIN CORP PLC\UK increase (decrease) in inventories for fiscal 2023 was -$56.12M, a 254.09% decline from fiscal 2022.
- AMARIN CORP PLC\UK increase (decrease) in inventories for fiscal 2022 was $36.42M, a 78.20% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$31.84M 10-Q · filed 2026-07-29 | -$29.74M derived: sum of 3 quarters · filed 2026-07-29 | -$46.76M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$12.32M 10-Q · filed 2026-04-29 | -$10.22M derived: sum of 2 quarters · filed 2026-04-29 | -$27.25M derived: sum of 3 quarters · filed 2026-04-29 | -$33.31M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$14.92M derived: sum of 2 quarters · filed 2026-03-02 | -$20.98M derived: sum of 3 quarters · filed 2026-07-29 | -$34.88M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$17.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$23.09M derived: sum of 2 quarters · filed 2026-07-29 | -$36.98M 10-Q · filed 2025-10-29 | -$104.21M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$6.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$19.96M 10-Q · filed 2026-07-29 | -$87.19M derived: sum of 3 quarters · filed 2026-07-29 | -$99.87M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$13.89M 10-Q · filed 2026-04-29 | -$81.13M derived: sum of 2 quarters · filed 2026-04-29 | -$93.81M derived: sum of 3 quarters · filed 2026-04-29 | -$112.61M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$67.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$79.91M derived: sum of 2 quarters · filed 2026-03-02 | -$98.72M derived: sum of 3 quarters · filed 2026-03-02 | -$105.44M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$12.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$31.48M derived: sum of 2 quarters · filed 2025-10-29 | -$38.21M 10-Q · filed 2025-10-29 | -$48.23M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$18.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$25.53M 10-Q · filed 2025-07-30 | -$35.55M derived: sum of 3 quarters · filed 2026-03-02 | -$38.64M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$6.73M 10-Q · filed 2025-05-07 | -$16.75M derived: sum of 2 quarters · filed 2026-03-02 | -$19.83M derived: sum of 3 quarters · filed 2026-03-02 | -$40.04M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | -$10.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$13.11M derived: sum of 2 quarters · filed 2026-03-02 | -$33.31M derived: sum of 3 quarters · filed 2026-03-02 | -$56.12M 10-K · filed 2026-03-02 |
| 2023-09-30 | -$3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$23.29M derived: sum of 2 quarters · filed 2024-10-30 | -$46.10M 10-Q · filed 2024-10-30 | -$69.32M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | -$20.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$43.01M 10-Q · filed 2024-07-31 | -$66.23M derived: sum of 3 quarters · filed 2025-03-12 | -$86.69M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | -$22.81M 10-Q · filed 2024-05-01 | -$46.03M derived: sum of 2 quarters · filed 2025-03-12 | -$66.48M derived: sum of 3 quarters · filed 2025-03-12 | -$39.33M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | -$23.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$43.67M derived: sum of 2 quarters · filed 2025-03-12 | -$16.52M derived: sum of 3 quarters · filed 2025-03-12 | $36.42M 10-K · filed 2025-03-12 |
| 2022-09-30 | -$20.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $6.70M derived: sum of 2 quarters · filed 2023-11-01 | $59.64M 10-Q · filed 2023-11-01 | $106.30M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $27.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $80.09M 10-Q · filed 2023-08-02 | $126.76M derived: sum of 3 quarters · filed 2024-02-29 | $163.57M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $52.94M 10-Q · filed 2023-05-03 | $99.60M derived: sum of 2 quarters · filed 2024-02-29 | $136.41M derived: sum of 3 quarters · filed 2024-02-29 | $177.98M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $46.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $83.47M derived: sum of 2 quarters · filed 2024-02-29 | $125.04M derived: sum of 3 quarters · filed 2024-02-29 | $167.07M 10-K · filed 2024-02-29 |
| 2021-09-30 | $36.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $78.38M derived: sum of 2 quarters · filed 2022-10-27 | $120.40M 10-Q · filed 2022-10-27 | $160.74M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $41.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $83.59M 10-Q · filed 2022-08-03 | $123.92M derived: sum of 3 quarters · filed 2023-03-01 | $147.61M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $42.03M 10-Q · filed 2022-05-04 | $82.36M derived: sum of 2 quarters · filed 2023-03-01 | $106.05M derived: sum of 3 quarters · filed 2023-03-01 | $138.77M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $40.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $64.02M derived: sum of 2 quarters · filed 2023-03-01 | $96.74M derived: sum of 3 quarters · filed 2023-03-01 | $112.09M 10-K · filed 2023-03-01 |
| 2020-09-30 | $23.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $56.41M derived: sum of 2 quarters · filed 2021-11-03 | $71.76M 10-Q · filed 2021-11-03 | $93.97M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $32.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $48.08M 10-Q · filed 2021-08-05 | $70.29M derived: sum of 3 quarters · filed 2022-03-01 | $78.58M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $15.35M 10-Q · filed 2021-04-29 | $37.56M derived: sum of 2 quarters · filed 2022-03-01 | $45.85M derived: sum of 3 quarters · filed 2022-03-01 | $34.21M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $22.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $30.50M derived: sum of 2 quarters · filed 2022-03-01 | $18.86M derived: sum of 3 quarters · filed 2022-03-01 | $18.97M 10-K · filed 2022-03-01 |
| 2019-09-30 | $8.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$3.35M derived: sum of 2 quarters · filed 2020-11-05 | -$3.25M 10-Q · filed 2020-11-05 | $10.88M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$11.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$11.53M 10-Q · filed 2020-08-04 | $2.60M derived: sum of 3 quarters · filed 2021-02-25 | $6.17M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $107.00K 10-Q · filed 2020-04-30 | $14.24M derived: sum of 2 quarters · filed 2021-02-25 | $17.82M derived: sum of 3 quarters · filed 2021-02-25 | $22.80M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $14.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $17.71M derived: sum of 2 quarters · filed 2021-02-25 | $22.70M derived: sum of 3 quarters · filed 2021-02-25 | $27.54M 10-K · filed 2021-02-25 |
| 2018-09-30 | $3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $8.57M derived: sum of 2 quarters · filed 2019-11-05 | $13.41M 10-Q · filed 2019-11-05 | $15.12M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $9.83M 10-Q · filed 2019-07-31 | $11.54M derived: sum of 3 quarters · filed 2020-02-25 | $15.28M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $4.84M 10-Q · filed 2019-05-01 | $6.55M derived: sum of 2 quarters · filed 2020-02-25 | $10.29M derived: sum of 3 quarters · filed 2020-02-25 | $11.22M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $5.45M derived: sum of 2 quarters · filed 2020-02-25 | $6.38M derived: sum of 3 quarters · filed 2020-02-25 | $9.75M 10-K · filed 2020-02-25 |
| 2017-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $4.67M derived: sum of 2 quarters · filed 2018-11-01 | $8.04M 10-Q · filed 2018-11-01 | $8.78M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $935.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $4.31M 10-Q · filed 2018-08-01 | $5.04M derived: sum of 3 quarters · filed 2019-02-27 | $4.51M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $3.37M 10-Q · filed 2018-05-02 | $4.11M derived: sum of 2 quarters · filed 2019-02-27 | $3.57M derived: sum of 3 quarters · filed 2019-02-27 | $2.54M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $734.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $201.00K derived: sum of 2 quarters · filed 2019-02-27 | -$837.00K derived: sum of 3 quarters · filed 2019-02-27 | $1.52M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$533.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$1.57M derived: sum of 2 quarters · filed 2017-11-01 | $788.00K 10-Q · filed 2017-11-01 | $69.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $1.32M 10-Q · filed 2017-08-02 | $602.00K derived: sum of 3 quarters · filed 2018-02-27 | -$193.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $2.36M 10-Q · filed 2017-05-03 | $1.64M derived: sum of 2 quarters · filed 2018-02-27 | $845.00K derived: sum of 3 quarters · filed 2018-02-27 | $5.16M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$719.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$1.51M derived: sum of 2 quarters · filed 2018-02-27 | $2.80M derived: sum of 3 quarters · filed 2018-02-27 | $5.25M 10-K · filed 2018-02-27 |
| 2015-09-30 | -$795.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.52M derived: sum of 2 quarters · filed 2016-11-03 | $5.97M 10-Q · filed 2016-11-03 | $7.82M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $4.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $6.77M 10-Q · filed 2016-08-04 | $8.61M derived: sum of 3 quarters · filed 2017-03-01 | $3.36M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.45M 10-Q · filed 2016-05-05 | $4.30M derived: sum of 2 quarters · filed 2017-03-01 | -$960.00K derived: sum of 3 quarters · filed 2017-03-01 | -$5.65M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$3.41M derived: sum of 2 quarters · filed 2017-03-01 | -$8.10M derived: sum of 3 quarters · filed 2017-03-01 | -$12.96M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$9.94M derived: sum of 2 quarters · filed 2015-11-04 | -$14.80M 10-Q · filed 2015-11-04 | -$15.20M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$4.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$9.55M 10-Q · filed 2015-08-06 | -$9.94M derived: sum of 3 quarters · filed 2016-02-25 | -$11.37M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$4.86M 10-Q · filed 2015-05-08 | -$5.25M derived: sum of 2 quarters · filed 2016-02-25 | -$6.68M derived: sum of 3 quarters · filed 2016-02-25 | -$5.61M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$1.82M derived: sum of 2 quarters · filed 2016-02-25 | -$744.00K derived: sum of 3 quarters · filed 2016-02-25 | $5.43M 10-K · filed 2016-02-25 |
| 2013-09-30 | -$1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$352.00K derived: sum of 2 quarters · filed 2014-11-06 | $5.82M 10-Q · filed 2014-11-06 | $18.09M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $7.25M 10-Q · filed 2014-08-07 | $19.52M derived: sum of 3 quarters · filed 2015-03-03 | |
| 2013-03-31 | $6.17M 10-Q · filed 2014-05-09 | $18.45M derived: sum of 2 quarters · filed 2015-03-03 | ||
| 2012-12-31 | $12.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $21.26M 10-K · filed 2015-03-03 | ||
| 2012-09-30 | $8.99M 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |